• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧盟呼吸护理协会(EUFOREA)提升呼吸护理标准:2024年4月欧盟议会研讨会报告

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

作者信息

Hellings P W, Conti D M, Bertels X, Backer V, Brusselle G, De Corso E, Fokkens W J, Fox A T, Gevaert P, Lau S, Liva G, Palkonen S, Papi A, Scheire S, Schmid-Grendelmeier P, Shire C M E, Smith P, Teeling M T A, Yorgancioglu A, Scadding G K

机构信息

Department of Otorhinolaryngology, Laboratory of Upper Airways Research, University of Ghent, Ghent, Belgium.

Department of Microbiology and Immunology, Allergy and Clinical Immunology Research Unit, KU Leuven, Leuven, Belgium.

出版信息

Front Allergy. 2025 Feb 24;6:1540499. doi: 10.3389/falgy.2025.1540499. eCollection 2025.

DOI:10.3389/falgy.2025.1540499
PMID:40065834
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11891202/
Abstract

In April 2024, the European Summit " was organized by the European Forum for Research and Education in Allergy and Airway Diseases (EUFOREA) in the European Parliament and hosted by Members of the European Parliament Dorien Rookmaker and Mislav Kolakušić. The aim of the Summit was to respond to the need of European patients suffering from chronic respiratory diseases (CRDs) by joining forces with European and global organisations in the management of the epidemics of CRD, recognising the weaknesses of current care models and focussing on collaboration to improve care and prevention. Participants belonging to International and National Societies and Committees from the European Rhinologic Society (ERS), International Rhinologic Society (IRS), Belgian Respiratory Society (BeRS), Global Initiative for Asthma (GINA), Global Initiative for Chronic Obstructive Lung Disease (GOLD), Global Alliance against Chronic Respiratory Diseases (GARD), and from the European Federation of Allergy and Airways Diseases Patients Associations (EFA) and the EUFOREA's Patient Advisory Board (PAB) described their vision and action plan to work in partnership to raise the bar in respiratory care. This report summarizes the contributions of the representatives of different European stakeholders in the field of CRDs.

摘要

2024年4月,欧洲过敏与气道疾病研究与教育论坛(EUFOREA)在欧洲议会组织了此次欧洲峰会,由欧洲议会议员多里安·罗克马克尔(Dorien Rookmaker)和米斯拉夫·科拉库希奇(Mislav Kolakušić)主持。此次峰会的目的是通过与欧洲及全球组织携手应对慢性呼吸道疾病(CRD)疫情,认识到当前护理模式的不足,并专注于合作以改善护理和预防工作,从而满足欧洲慢性呼吸道疾病患者的需求。来自国际和国家学会及委员会的与会者,包括欧洲鼻科学会(ERS)、国际鼻科学会(IRS)、比利时呼吸学会(BeRS)、全球哮喘防治创议(GINA)、慢性阻塞性肺疾病全球倡议(GOLD)、全球抗击慢性呼吸道疾病联盟(GARD),以及欧洲过敏与气道疾病患者协会联合会(EFA)和EUFOREA患者咨询委员会(PAB),介绍了他们携手合作提升呼吸护理水平的愿景和行动计划。本报告总结了欧洲CRD领域不同利益相关者代表的贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/11891202/19a6f9e0111c/falgy-06-1540499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/11891202/74f67fba6c7f/falgy-06-1540499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/11891202/765b5bc8a795/falgy-06-1540499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/11891202/19a6f9e0111c/falgy-06-1540499-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/11891202/74f67fba6c7f/falgy-06-1540499-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/11891202/765b5bc8a795/falgy-06-1540499-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0326/11891202/19a6f9e0111c/falgy-06-1540499-g003.jpg

相似文献

1
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.欧盟呼吸护理协会(EUFOREA)提升呼吸护理标准:2024年4月欧盟议会研讨会报告
Front Allergy. 2025 Feb 24;6:1540499. doi: 10.3389/falgy.2025.1540499. eCollection 2025.
2
European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017).欧洲慢性呼吸道疾病预防与自我管理峰会:欧盟议会峰会报告(2017年3月29日)
Clin Transl Allergy. 2017 Dec 27;7:49. doi: 10.1186/s13601-017-0186-3. eCollection 2017.
3
European symposium on precision medicine in allergy and airways diseases: report of the European Union parliament symposium (October 14, 2015).欧洲过敏与气道疾病精准医学研讨会:欧洲议会研讨会报告(2015 年 10 月 14 日)。
Rhinology. 2015 Dec;53(4):303-7. doi: 10.4193/Rhino15.400.
4
EUFOREA summit in Brussels 2023: .2023年在布鲁塞尔举行的欧洲肥胖研究协会峰会:.
Front Allergy. 2023 Jul 27;4:1236977. doi: 10.3389/falgy.2023.1236977. eCollection 2023.
5
European Symposium on Precision Medicine in Allergy and Airways Diseases: Report of the European Union Parliament Symposium (October 14, 2015).欧洲过敏和气道疾病精准医学研讨会:欧洲议会研讨会报告(2015 年 10 月 14 日)。
Allergy. 2016 May;71(5):583-7. doi: 10.1111/all.12819. Epub 2016 Mar 8.
6
European symposium on the awareness of allergy: report of the promotional campaign in the European Parliament (26-28 April 2016).欧洲过敏意识研讨会:在欧洲议会的宣传活动报告(2016 年 4 月 26-28 日)。
Allergy. 2017 Feb;72(2):173-176. doi: 10.1111/all.13058.
7
EUFOREUM Berlin 2023: Optimizing care for type 2 inflammatory diseases from clinic to AI: A pediatric focus.EUFOREUM 柏林 2023 年会:从临床到人工智能优化 2 型炎症性疾病的治疗:儿科重点。
Pediatr Allergy Immunol. 2024 Jul;35(7):e14183. doi: 10.1111/pai.14183.
8
EUFOREA Rhinology Research Forum 2016: report of the brainstorming sessions on needs and priorities in rhinitis and rhinosinusitis.2016年欧洲鼻科学研究论坛:关于鼻炎和鼻窦炎需求与优先事项的头脑风暴会议报告
Rhinology. 2017 Sep 1;55(3):202-210. doi: 10.4193/Rhin17.028.
9
GARD, a new way to battle with chronic respiratory diseases, from disease oriented programmes to global partnership.全球哮喘防治创议(GARD),一种与慢性呼吸道疾病作斗争的新方法,从以疾病为导向的项目到全球伙伴关系。
J Thorac Dis. 2017 Nov;9(11):4676-4689. doi: 10.21037/jtd.2017.11.91.
10
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned.欧盟罕见病组织(EUFOREA)2024年举办的2型炎症欧洲生物制剂培训课程:关键事实与经验教训
Front Allergy. 2024 Dec 12;5:1517122. doi: 10.3389/falgy.2024.1517122. eCollection 2024.

本文引用的文献

1
Prevalence of chronic rhinosinusitis without/with nasal polyps according to severity in Spain.根据严重程度,西班牙无/伴鼻息肉慢性鼻-鼻窦炎的流行情况。
Rhinology. 2024 Aug 1;62(4):421-431. doi: 10.4193/Rhin23.341.
2
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma.哮喘前期:一个有用的概念?一篇欧盟呼吸健康联盟(EUFOREA)的论文。第2部分——迟发性嗜酸性粒细胞性哮喘
Front Allergy. 2024 May 15;5:1404735. doi: 10.3389/falgy.2024.1404735. eCollection 2024.
3
Nasal polyp syndrome: a patient-centred term for CRSwNP by EUFOREA.
鼻息肉综合征:欧洲鼻科学与鼻-鼻窦疾病研究学会提出的以患者为中心的慢性鼻-鼻窦炎伴鼻息肉术语。
Front Allergy. 2024 Mar 20;5:1372919. doi: 10.3389/falgy.2024.1372919. eCollection 2024.
4
MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases.MASK-air:经合组织(经济合作与发展组织)慢性病综合护理公共卫生最佳实践。
J Allergy Clin Immunol Pract. 2024 Aug;12(8):2010-2016.e7. doi: 10.1016/j.jaip.2024.03.024. Epub 2024 Mar 21.
5
Lung-function trajectories: relevance and implementation in clinical practice.肺功能轨迹:临床实践中的相关性和实施。
Lancet. 2024 Apr 13;403(10435):1494-1503. doi: 10.1016/S0140-6736(24)00016-3. Epub 2024 Mar 12.
6
Pre-asthma: a useful concept for prevention and disease-modification? A EUFOREA paper. Part 1-allergic asthma.哮喘前期:对预防和疾病改善而言是个有用的概念?一篇欧盟呼吸研究与创新联盟(EUFOREA)的论文。第1部分——过敏性哮喘
Front Allergy. 2024 Jan 30;4:1291185. doi: 10.3389/falgy.2023.1291185. eCollection 2023.
7
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.EPOS2020/EUFOREA 专家意见:慢性鼻窦炎伴鼻息肉患者疾病分型和治疗目标的定义。
Rhinology. 2024 Jun 1;62(3):287-298. doi: 10.4193/Rhin23.415.
8
Quantifying the benefits of early sublingual allergen immunotherapy tablet initiation in children.量化儿童早期舌下过敏原免疫治疗片起始治疗的获益。
Allergy. 2024 Apr;79(4):1018-1027. doi: 10.1111/all.15985. Epub 2023 Dec 26.
9
EUFOREA/EPOS2020 statement on the clinical considerations for chronic rhinosinusitis with nasal polyps care.EUFOREA/EPOS2020 关于慢性鼻-鼻窦炎伴鼻息肉患者护理的临床考量声明。
Allergy. 2024 May;79(5):1123-1133. doi: 10.1111/all.15982. Epub 2023 Dec 18.
10
Prevalence of multiple long-term conditions (multimorbidity) in England: a whole population study of over 60 million people.英格兰多种长期病症(共病)的患病率:一项针对6000多万人的全人群研究。
J R Soc Med. 2024 Mar;117(3):104-117. doi: 10.1177/01410768231206033. Epub 2023 Oct 31.